Can Fite Biofarma Ltd.
13F holders, Q4 2024 (December 31)13holders +1
2new positions
2sold out
$1.63avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were Morgan Stanley ($53K), Rhumbline Advisers ($44K) and BNP Paribas Financial Markets ($41K).
- Company
- Can Fite Biofarma Ltd.
- CUSIP
- 13471N300
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $46K |
| Exits | 2 | $1.3M |
All 13F filers, Q3 2024 → Q4 2024: 38,521 shares bought and 678,428 shares sold, net −639,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Morgan Stanley | 0.00% | Reduce -35.8% | 32,512 | $53K |
| Rhumbline Advisers | 0.00% | Add +58.6% | 26,880 | $44K |
| BNP Paribas Financial Markets | 0.00% | New | 25,185 | $41K |
| Two Sigma Securities, LLC | 0.01% | Reduce -34.4% | 19,395 | $32K |
| Kohmann Bosshard Financial Services, LLC | 0.00% | New | 3,401 | $6K |
| Fifth Third Bancorp | 0.00% | No change | 3,000 | $5K |
| Wells Fargo & Company | 0.00% | No change | 2,500 | $4K |
| National Bank of Canada | 0.00% | No change | 600 | $975 |
| Citigroup Inc. | 0.00% | No change | 553 | $899 |
| Activest Wealth Management | 0.00% | No change | 200 | $325 |
| Osaic Holdings, Inc. | 0.00% | Reduce -2.7% | 180 | $293 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 20 | $32 |
| SBI Securities Co., Ltd. | 0.00% | — | 1 | $2 |
"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.